ORPHA:293936
EDICT syndrome
Also known as: Autosomal dominant keratoconus with early-onset anterior polar cataracts · Endothelial dystrophy-iris hypoplasia-congenital cataract-stromal thinning syndrome · Familial keratoconus with cataract · KTCNCT
Publications
2,390
Trials
0
Interventional, condition-specific
Researchers
396
Distinct authors in sample
Gene link
MIR184
Definitive
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare, , eye disorder representing a constellation of inherited ocular findings, including early-onset or cataracts, corneal stromal thinning, early-onset keratoconus, corneal endothelial , and iris hypoplasia.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013678
- OMIM:614303
- UMLS:C3280392
Additional Mondo synonyms (3)
autosomal dominant keratoconus with early-onset anterior polar cataracts · endothelial dystrophy-iris hypoplasia-congenital cataract-stromal thinning syndrome · familial keratoconus with cataract
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Definitive — MIR184
- LiteraturePresent
2,390 matched papers (774 in last 10 years) Source
- Phenotype characterisedPresent
7 HPO annotations (e.g. Reduced visual acuity; Microcornea; Astigmatism) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (MIR184).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
7
Associated phenotypes · MONDO:0013678
- Reduced visual acuity
- Microcornea
- Astigmatism
- Keratoconus
- Anterior polar cataract
Showing 5 of 7 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
2,390
2,390 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
2,390 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
774 in the last 10 years · low confidence
Phrase hits: 67 · MeSH hits: 0
Who's working on it?
396
Distinct author names in 67 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Gottsch JD4 papers · 2012
Center for Corneal Genetics, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Papers in Europe PMC - 02Suzuki HI4 papers · 2025
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Papers in Europe PMC - 03Banfi S3 papers · 2026
Telethon Institute of Genetics and Medicine, Pozzuoli 80078, Italy; Medical Genetics, Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, 80138 Naples, Italy; European Retinal Dystrophy Consortium; banfi@tigem.it graeme.black@manchester.ac.uk.
Papers in Europe PMC - 04Iliff BW3 papers · 2012
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Papers in Europe PMC - 05Riazuddin SA3 papers · 2012
Center for Corneal Genetics, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Papers in Europe PMC - 06Abu-Amero KK2 papers · 2015
Ophthalmic Genetics Laboratory, Department of Ophthalmology, College of Medicine, King Saud University, P.O. Box 245, Riyadh 11411, Saudi Arabia ; Glaucoma Research Chair, Department of Ophthalmology, College of Medicine, King Saud University, P.O. Box 245, Riyadh 11411, Saudi Arabia ; Department of Ophthalmology, College of Medicine, University of Florida, Jacksonville, FL 32209, USA.
Papers in Europe PMC - 07Asada K2 papers · 2023
Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Papers in Europe PMC - 08Campbell M2 papers · 2012
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Institute of Pathology, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BL, UK
Papers in Europe PMC - 09Conte I2 papers · 2015
Telethon Institute of Genetics and Medicine, Pozzuoli 80078, Italy;
Papers in Europe PMC - 10Dash DP2 papers · 2011Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for EDICT syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("EDICT syndrome" OR "Autosomal dominant keratoconus with early-onset anterior polar cataracts" OR "Endothelial dystrophy-iris hypoplasia-congenital cataract-stromal thinning syndrome" OR "Familial keratoconus with cataract" OR "KTCNCT") OR ("MIR184" OR "MIR184 syndrome" OR "MIR184-related" OR "EDICT" OR "EDICT-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"EDICT syndrome" OR "Autosomal dominant keratoconus with early-onset anterior polar cataracts" OR "Endothelial dystrophy-iris hypoplasia-congenital cataract-stromal thinning syndrome" OR "Familial keratoconus with cataract" OR "KTCNCT"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (2390) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T12:24:48.684Z